Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics

“I’m very interested in finding opportunities in the anti-infective space, particularly around multi-drug resistant organisms,” Gottlieb, now at New Enterprise Associates, told Reuters. “Anti-infectives have been unloved for a very long time. There’s a huge clinical need.”